Tectonic Therapeutic TECX
NASDAQ TECX
$22.67 -0.62 (-2.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Cash & Equivalents (2017 - 2026)

Updated

Tectonic Therapeutic's Cash & Equivalents was $227.1 million in Q2 2026, down 21.0% from $287.38 million a year earlier and down 4.1% from the prior quarter.

Analysis

Tectonic Therapeutic (TECX) Cash & Equivalents (2017 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Tectonic Therapeutic came in at $253.8 million, up 79.7% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $141.24 million in FY2024 (+390.9%), $28.77 million in FY2023 (-68.9%), $92.56 million in FY2022 (-51.2%) and $189.57 million in FY2021 (-27.0%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2024.
  • Compared with a year earlier, Cash & Equivalents was higher in four of the last six quarters, with growth averaging 91.8%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q4 2024 (growth of 390.9%); the worst was Q3 2023 (a decline of 94.5%).
  • Per Business Quant data, TECX's Cash & Equivalents in the three quarters before Q2 2026 was $236.9 million (Q1 2026), $253.8 million (Q4 2025) and $268.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Tectonic Therapeutic 447.99 Mn 447.99 Mn - 227.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 227.10 Mn
Mar 31, 2026 236.90 Mn
Dec 31, 2025 253.80 Mn
Sep 30, 2025 268.44 Mn
Jun 30, 2025 287.38 Mn
Mar 31, 2025 306.25 Mn
Dec 31, 2024 141.24 Mn
Sep 30, 2024 159.10 Mn
Jun 30, 2024 185.12 Mn
Mar 31, 2024 18.75 Mn
Dec 31, 2023 28.77 Mn
Sep 30, 2023 6.33 Mn
Jun 30, 2023 14.93 Mn
Mar 31, 2023 72.33 Mn
Dec 31, 2022 92.56 Mn
Sep 30, 2022 115.97 Mn
Jun 30, 2022 132.41 Mn
Mar 31, 2022 161.66 Mn
Dec 31, 2021 189.57 Mn
Sep 30, 2021 201.37 Mn
API Access

Tectonic Therapeutic Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TECX&period=max&api_key=YOUR_API_KEY